Not applicableLooking for participantsNCT03868293What this trial is testingLow Intensity Focused Ultrasound Epilepsy: A Pilot TrialWho this might be right forDrug Resistant Epilepsy Brigham and Women's Hospital 10
Not applicableLooking for participantsNCT07737509What this trial is testingUnderstanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample AnalysisWho this might be right forAdvanced Solid Tumours Institute of Cancer Research, United Kingdom 5,000
Testing effectiveness (Phase 2)Study completedNCT00033163What this trial is testingA Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVWho this might be right forHIV InfectionsHepatitis B National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableLooking for participantsNCT06545214What this trial is testingCaracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsyWho this might be right forEpilepsy Hospices Civils de Lyon 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07833098What this trial is testingA Phase II Study of VB19055 in Uncontrolled or Resistant HypertensionWho this might be right forHypertensionResistant HypertensionUncontrolled Hypertension Zhejiang Yangli Pharmaceutical Technology Co., Ltd. 240
Large-scale testing (Phase 3)Ended earlyNCT04378075What this trial is testingEvaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory EpilepsyWho this might be right forMitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more PTC Therapeutics 68
Post-approval studies (Phase 4)Study completedNCT01639066What this trial is testingTenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis BWho this might be right forChronic Viral Hepatitis B Without Delta-agent Asan Medical Center 102
Post-approval studies (Phase 4)Study completedNCT06687473What this trial is testingSusceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori StrainsWho this might be right forHelicobacter PyloriDrug Resistance, MultipleVirulence Factor National Cheng-Kung University Hospital 13
Not applicableStudy completedNCT03057756What this trial is testingTreatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug ResistanceWho this might be right forMulti-drug Resistant Tuberculosis Centre de Recherche Médicale de Lambaréné 23
Not applicableLooking for participantsNCT07592195What this trial is testingA Study on the Effects of Breathing Exercises and Aerobic Exercise on the Health of Men in Drug RehabilitationWho this might be right forDisorders, Substance Related Southwest Medical University 90
Not applicableEnded earlyNCT01381757What this trial is testingUtility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in MaliWho this might be right forTuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more National Institute of Allergy and Infectious Diseases (NIAID) 34
Not applicableUnknownNCT05958641What this trial is testingConstruction of Early Warning Model for the New Psychoactive Substances Using in AdolescentsWho this might be right forDrug Addiction Wei XIA, PhD 200
Testing effectiveness (Phase 2)Study completedNCT03643107What this trial is testingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Who this might be right forMetastatic Castration-Resistant Prostate Cancer Patients Allarity Therapeutics 15
Testing effectiveness (Phase 2)Ended earlyNCT02226172What this trial is testingSingle-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With RuxolitinibWho this might be right forPrimary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis Pfizer 21
Large-scale testing (Phase 3)Study completedNCT01193257What this trial is testingStudy Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.Who this might be right forProstate Cancer Millennium Pharmaceuticals, Inc. 1,099
Not applicableUnknownNCT04771065What this trial is testingDeep Brain Stimulation of the Anterior Nucleus of the Thalamus in Intractable EpilepsyWho this might be right forRefractory Epilepsy University Hospital, Montpellier 10
Early research (Phase 1)Study completedNCT02286986What this trial is testingCannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant EpilepsyWho this might be right forEpilepsy University of Utah 26
Post-approval studies (Phase 4)Study completedNCT00515021What this trial is testingDiurnal Variation of Plasminogen Activator Inhibitor-1Who this might be right forMetabolic Syndrome X Vanderbilt University Medical Center 21
Testing effectiveness (Phase 2)Temporarily pausedNCT02354014What this trial is testingPharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TBWho this might be right forTuberculosis, Multidrug-Resistant Janssen Research & Development, LLC 60
Early research (Phase 1)UnknownNCT03575299What this trial is testingClinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT CellsWho this might be right forMulti-drug Resistant Tuberculosis Zhinan Yin, Ph.D. 45